CytoImmune Therapeutics logo

CytoImmune Therapeutics

CytoImmune Therapeutics, LLC develops novel, coordinated immunotherapy solutions for patients.

31 employees · est. 2019 · Monrovia, United States

VS
FineImmu logo

FineImmu

Creating future health with advanced cell therapy drugs and precision immunodiagnostic products.

est. 2018

FineImmu is the older company (2019 vs 2018).

Side-by-Side Comparison

CytoImmune Therapeutics FineImmu
Founded
2019 2018 older
Headquarters
Monrovia, United States Not tracked yet
Employees
31 Not tracked yet
Industry
Biotechnology, Health and Wellness Biopharma, Biotechnology, Health Care
Funding Stage
Not tracked yet Seed
Total Funding
Not tracked yet $90.00M
Funding Rounds
Not tracked yet 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Immunotherapy, Bi-specific Antibody, CAR Technology, NK Cell Therapy, T-cell Therapy, Coordinated Immunotherapy, Cancer Treatment, Therapeutic Development, Immunology, Bispecific Antibody Therapy, Cell Therapy, Oncology, Innovative Treatment, Immune Response Cell Therapy, Immunotherapy, Precision Medicine, Immunodiagnostic, PD-1, PD-L1, Immune Checkpoint Inhibitors, Cancer Therapy, Drug Development, Biopharmaceuticals
Website
cytoimmune.com fineimmu.com
CytoImmune Therapeutics logo

About CytoImmune Therapeutics

CytoImmune Therapeutics is a biotechnology startup with a vision to develop novel, coordinated immunotherapy solutions for patients. The company's CoalesceNT™ platform integrates bispecific antibody (biAb) and chimeric antigen receptor (CAR) technology to orchestrate an immune response with natural...

FineImmu logo

About FineImmu

FineImmu, established in 2018, is a biopharmaceutical and biotechnology startup dedicated to revolutionizing healthcare with advanced cell therapy drugs and precision immunodiagnostic products. The company's slogan "Creating future health with advanced cell therapy drugs and precision immunodiagnost...

We will tell you when either one moves

BounceWatch watches CytoImmune Therapeutics and FineImmu for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at CytoImmune Therapeutic... and FineImmu — by email.

Frequently Asked Questions

CytoImmune Therapeutics — CytoImmune Therapeutics, LLC develops novel, coordinated immunotherapy solutions for patients.. FineImmu — Creating future health with advanced cell therapy drugs and precision immunodiagnostic products.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CytoImmune Therapeutics has raised undisclosed funding while FineImmu has raised $90.00M.
CytoImmune Therapeutics and FineImmu operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CytoImmune Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at CytoImmune Therapeutics on 18 Nov 2024, and FineImmu on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes